For immediate release
Derwent London plc
("Derwent London"/"the Company")
Notification of interests of Directors and Persons Discharging
Managerial Responsibility ("PDMR")
The Company announces the following changes to the interests of Directors in the Company's ordinary shares of 5p each ('Shares').
Grant of Options
On 15 April 2021, the Company granted options over 13,914 ordinary shares of 5 pence in the Company ("Options"), in aggregate, pursuant to the Derwent London Sharesave Plan ("Sharesave Plan").
The three-year contract for the Options will start on 1 June 2021. These Options are exercisable at a price of £25.93 per share from 1 June 2024 and are not subject to any performance conditions. The exercise price has been determined in accordance with the valuation methodology agreed with HM Revenue & Customs and the rules of the Sharesave Plan.
Within the Options described above, the following Options were granted to PDMRs:
| Name | Role | Options granted under Sharesave Plan |
| Damian M A Wisniewski | Chief Financial Officer | 173 |
| Emily J Prideaux | Director | 347 |
This announcement is made in accordance with Article 19 of the Market Abuse Regulation and Rule 3.1 of the Disclosure and Transparency Rules.
Enquiries:
D A Lawler
Company Secretary
15 April 2021
020 7659 3000
The information set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
| 1. | Details the person discharging managerial responsibilities / person closely associated | ||||||||
| a) | Name | Damian M A Wisniewski | |||||||
| 2. | Reason for the notification | ||||||||
| a) | Position / status | Chief Financial Officer | |||||||
| b) | Initial notification / Amendment | Initial notification
| |||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||||
| a) | Name | Derwent London plc | |||||||
| b) | LEI | 213800BXKQ9KZNUR1M61 | |||||||
| 4. | Details of the transaction (s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||||
| a) | Description of the financial instrument, type of instrument Identification code |
5p Ordinary shares in Derwent London plc
GB0002652740 | |||||||
| b) | Nature of the transaction | Grant of an option under the Derwent London Sharesave Plan. | |||||||
| c) | Price(s) and volume(s) |
| |||||||
| d) | Aggregated information - Aggregated volume - Price |
Not applicable - single transaction | |||||||
| e) | Date of the transaction | 15 April 2021 | |||||||
| f) | Place of the transaction | Outside a trading venue | |||||||
| 1. | Details the person discharging managerial responsibilities / person closely associated | ||||||||
| a) | Name | Emily J Prideaux | |||||||
| 2. | Reason for the notification | ||||||||
| a) | Position / status | Director | |||||||
| b) | Initial notification / Amendment | Initial notification
| |||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||||
| a) | Name | Derwent London plc | |||||||
| b) | LEI | 213800BXKQ9KZNUR1M61 | |||||||
| 4. | Details of the transaction (s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||||
| a) | Description of the financial instrument, type of instrument Identification code |
5p Ordinary shares in Derwent London plc
GB0002652740 | |||||||
| b) | Nature of the transaction | Grant of an option under the Derwent London Sharesave Plan. | |||||||
| c) | Price(s) and volume(s) |
| |||||||
| d) | Aggregated information - Aggregated volume - Price |
Not applicable - single transaction | |||||||
| e) | Date of the transaction | 15 April 2021 | |||||||
| f) | Place of the transaction | Outside a trading venue | |||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
